Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 31 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07532525
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
NCT06723457
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Recruiting
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
NCT04892277
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07609030
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
NCT05272384
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
NCT07283679
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
NCT05801913
- Conditions
- Hemic and Lymphatic Diseases, High Grade B-Cell Non-Hodgkin's Lymphoma, Immune System Diseases, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Recruiting
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
- Conditions
- B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States
NCT06313957
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China
- Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, China
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
NCT02332980
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +48 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04074746
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04578600
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +39 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01701986
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03003546
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT03994913
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
- First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
NCT01921387
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
NCT01897012
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01729806
- Conditions
- CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States